Cipla Gets U.S. FDA Warning Letter For Goa Unit
Cipla House in Mumbai. (Source: BloombergQuint)

Cipla Gets U.S. FDA Warning Letter For Goa Unit

Cipla Ltd. said it has received a “warning letter” from the U.S. drug regulator for its formulations plant in Goa.That comes after the U.S. Food and Drug Administration classified the plant as Offi...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.